TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange

Background: Sickle cell hemoglobinopathies are associated with end organ damage but very rarely present with a clinical and laboratory picture of microangiopathic hemolytic anemia (MAHA) and thrombocytopenia, characteristic of thrombotic microangiopathy (TMA). Case presentation: We present a patient...

Full description

Bibliographic Details
Main Authors: Sreenath Kodali, Preethi Ramachandran, Ivan N. Richard, Jen-Chin Wang
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Leukemia Research Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048919300421
id doaj-7485ae6bed354e6981f92db8cf550b19
record_format Article
spelling doaj-7485ae6bed354e6981f92db8cf550b192020-11-25T00:16:07ZengElsevierLeukemia Research Reports2213-04892019-01-0112TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchangeSreenath Kodali0Preethi Ramachandran1Ivan N. Richard2Jen-Chin Wang3Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, 11212 NY, USADivision of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, 11212 NY, USADivision of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, 11212 NY, USACorresponding author.; Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, 11212 NY, USABackground: Sickle cell hemoglobinopathies are associated with end organ damage but very rarely present with a clinical and laboratory picture of microangiopathic hemolytic anemia (MAHA) and thrombocytopenia, characteristic of thrombotic microangiopathy (TMA). Case presentation: We present a patient with HbSC disease who developed thrombotic microangiopathy, needing both RBC exchange transfusion and therapeutic plasma exchange (TPE) for complete clinical recovery. Conclusion: Although literature showed therapeutic plasma exchange alone can abrogate a similar clinical scenario, we did an in-depth review which concluded that in most of the TMA cases secondary to sickle cell disease, treatment with both with plasma exchange and red cell exchange transfusion are necessary. Keywords: Sickle cell disease, Red cell exchange, Plasma exchange, TMAhttp://www.sciencedirect.com/science/article/pii/S2213048919300421
collection DOAJ
language English
format Article
sources DOAJ
author Sreenath Kodali
Preethi Ramachandran
Ivan N. Richard
Jen-Chin Wang
spellingShingle Sreenath Kodali
Preethi Ramachandran
Ivan N. Richard
Jen-Chin Wang
TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange
Leukemia Research Reports
author_facet Sreenath Kodali
Preethi Ramachandran
Ivan N. Richard
Jen-Chin Wang
author_sort Sreenath Kodali
title TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange
title_short TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange
title_full TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange
title_fullStr TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange
title_full_unstemmed TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange
title_sort ttp-like syndrome associated with hemoglobin sc disease treated successfully with plasma and red cell exchange
publisher Elsevier
series Leukemia Research Reports
issn 2213-0489
publishDate 2019-01-01
description Background: Sickle cell hemoglobinopathies are associated with end organ damage but very rarely present with a clinical and laboratory picture of microangiopathic hemolytic anemia (MAHA) and thrombocytopenia, characteristic of thrombotic microangiopathy (TMA). Case presentation: We present a patient with HbSC disease who developed thrombotic microangiopathy, needing both RBC exchange transfusion and therapeutic plasma exchange (TPE) for complete clinical recovery. Conclusion: Although literature showed therapeutic plasma exchange alone can abrogate a similar clinical scenario, we did an in-depth review which concluded that in most of the TMA cases secondary to sickle cell disease, treatment with both with plasma exchange and red cell exchange transfusion are necessary. Keywords: Sickle cell disease, Red cell exchange, Plasma exchange, TMA
url http://www.sciencedirect.com/science/article/pii/S2213048919300421
work_keys_str_mv AT sreenathkodali ttplikesyndromeassociatedwithhemoglobinscdiseasetreatedsuccessfullywithplasmaandredcellexchange
AT preethiramachandran ttplikesyndromeassociatedwithhemoglobinscdiseasetreatedsuccessfullywithplasmaandredcellexchange
AT ivannrichard ttplikesyndromeassociatedwithhemoglobinscdiseasetreatedsuccessfullywithplasmaandredcellexchange
AT jenchinwang ttplikesyndromeassociatedwithhemoglobinscdiseasetreatedsuccessfullywithplasmaandredcellexchange
_version_ 1725384511791824896